The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.

Malaria (P. f/P. v) Antigen Testing Kit is a rapid self-performing, qualitative, two site sandwich immunoassay, utilizing whole blood for the detection of P.falciparum specific histidine rich protein-2 (P.f HRP-2) and P.vivax specific pLDH. The test may also be used for specific detection and differentiation of P. falciparum and P. vivax malaria in whole blood samples and for the follow up of anti-malarial therapy.

Influenza A/B Antigen Virus Testing Kit is a rapid qualitative assay that detects influenza type A (including the subtype H1N1) and B nucleoprotein antigens extracted from the nasal swab specimen. This device is used to aid in the differential diagnosis of influenza type A and B infection.

Treponema Pallidum /Syphilis Antibody Testing Kit is a rapid test for the visual detection of antibodies of Treponema Pallidum (TP) in whole blood/serum/plasma as an aid in the diagnosis of syphilis infection.

• Lateral flow immunoassay. • • Lateral flow test . • Sensitivity: 90.00% (180/200), 95% CI 73.47% to 97.89% • Specificity: 98.00% (98/100), 95% CI 92.96% to 99.76%

• Lateral flow test. • Sensitivity: 90.00% (180/200), 95% CI 73.47% to 97.89% • Specificity: 98.00% (98/100), 95% CI 92.96% to 99.76%